PTRKNasdaq StockholmHealth Information ServicesIFRS · SEK

Physitrack

Physitrack PLC is a UK-incorporated digital health company that operates a cloud-based platform for physiotherapy and wellbeing services. Its business combines software for healthcare providers, employer wellbeing tools, and related digital learning and care workflows delivered through its group of operating subsidiaries.

Revenue13.9m SEK
+701.6 %y/y
Operating profit (EBIT)-0.1m SEK
+98.1 %y/y
EBIT margin-0.9%
+375.1 ppy/y
Net income-6.5m SEK

Fiscal year 2025 · change from previous year

Development 2022–2025

-10-5051015m SEK2022: 8.6 m SEK2022: EBIT 0.11 m SEK20222023: 9.5 m SEK2023: EBIT 3.8 m SEK20232024: 1.7 m SEK2024: EBIT -6.5 m SEK20242025: 14 m SEK2025: EBIT -0.12 m SEK202514-0.12
RevenueOperating profit (EBIT)

Business

Share of revenue
Lifecare platform83 %

Software for physiotherapy providers covering care workflows, patient engagement, and digital exercise delivery.

Wellness platform17 %

Employee wellbeing software and related digital services for corporate customers.

Continuing education and content0 %

Physicourses and other learning content for clinicians and allied health professionals.

RTM and usage-based add-ons0 %

US remote therapeutic monitoring-related fees and other variable software charges.

Customers

Physitrack sells to healthcare providers, employers, and enterprise partners that need digital tools for patient engagement, rehabilitation workflows, or employee wellbeing. Its customer base includes physiotherapy clinics, healthcare systems, corporate wellbeing buyers, and channel partners that embed the platform into broader care or benefits offerings.

Physiotherapy providers

Clinics and therapy practices buy Lifecare and HEP tools to manage exercises, patient engagement, and care delivery.

Employers and HR buyers

Companies buy the Wellness platform to support employee wellbeing and engagement programs.

Enterprise healthcare accounts

Large provider groups and systems buy integrated software and RTM-enabled workflows for scale and compliance.

Partners and channel distributors

Partners use Physitrack products to extend their own healthcare or wellbeing offerings.

Clinicians and professional learners

Users access Physicourses and related education content to support continuing professional development.

Strategy

Physitrack’s strategy centers on scaling its SaaS platform, deepening enterprise adoption, and expanding workflow integration across healthcare and wellbeing use cases. The company is also pushing product-led innovation, including AI-enabled tools and RTM-related commercialization in the US, to increase customer stickiness and broaden monetization.

Scale Lifecare and enterprise adoptionMedium term

Lifecare is the core platform and enterprise wins improve recurring revenue visibility and retention.

Shift toward software-first monetizationShort term

Software subscriptions are more scalable than service-heavy revenue and better fit the group’s platform model.

Expand US RTM commercializationMedium term

RTM adds a usage-based revenue layer and strengthens the US value proposition for clinics.

Embed AI and automationMedium term

AI can improve product development speed, user experience, and operating efficiency in a software business.

Geography

Physitrack is headquartered in London and operates as a multinational group with subsidiaries and customers across multiple currencies and jurisdictions. The company describes itself as serving customers in more than 100 countries, while also highlighting North America, especially the United States, as a major commercial focus for its RTM-related offering.

Risks

Physitrack faces typical SaaS and digital health risks around regulation, data privacy, product innovation, and customer retention, with added exposure from operating across multiple currencies and jurisdictions. Its mix of healthcare workflows and wellbeing products also creates clinical, compliance, and intellectual property risks that can affect trust, adoption, and scalability.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Foreign exchange volatility1Regulatory and compliance risk2Clinical and data security risk3Innovation and competitive pressure4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Foreign exchange volatilityImpact: HighLikelihood: Medium

    The group transacts in multiple currencies while reporting in EUR, so exchange movements can affect revenue, costs, and cash flow.

    ExposureGBPEURUSDOther operating currencies
  2. Regulatory and compliance riskImpact: HighLikelihood: Medium

    Digital health and wellbeing products operate under healthcare, privacy, and local compliance rules across jurisdictions.

    ExposureHealthcare regulationPrivacy lawsLicensingRegistrations
  3. Clinical and data security riskImpact: HighLikelihood: Low

    Healthcare customers require reliable platforms and strong privacy controls, and failures can lead to reputational and contractual loss.

    ExposurePatient dataClinical contentEnterprise accounts
  4. Innovation and competitive pressureImpact: MediumLikelihood: Medium

    The market expects rapid product improvement, including AI-enabled functionality, so slower innovation can weaken retention and growth.

    ExposureProduct roadmapAI featuresUser experience
  5. Intellectual property protectionImpact: Medium

    The platform, content library, and workflows depend on defensible IP and freedom to operate.

    ExposureSoftwareContentClinical workflows

Accounting

Judgemental items
Revenue recognition across SaaS and usage-based fees

The group has recurring subscriptions plus RTM-related variable charges, so timing and allocation can affect reported revenue patterns.

Impact: Subscription revenue and per-patient RTM add-ons

Foreign currency translation

Operations span GBP, EUR, USD and other currencies while reporting in EUR, creating translation and transaction effects.

Impact: Reported revenue, expenses, and equity

Expected credit loss on receivables

Trade receivables are measured using expected credit loss assumptions, which can affect asset values and operating results.

Impact: Customer receivables and impairment charges

Fair value measurement of financial assets

The group has disclosed fair value accounting for certain investments, which can introduce volatility in other income or profit.

Impact: Investment valuation and OCI/P&L

Impairment of intangible assets and software development

A software-led business depends on capitalized development and acquired intangibles that may require impairment testing if performance weakens.

Impact: Balance sheet carrying values and amortization

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026